Exploration Capital Fund, LP 4
4 · Fresh Tracks Therapeutics, Inc. · Filed Dec 6, 2023
Insider Transaction Report
Form 4
Exploration Capital Fund, LP
10% Owner
Transactions
- Purchase
Common Stock
2023-12-05$0.85/sh−5,188$4,410→ 682,767 total - Purchase
Common Stock
2023-12-04$0.85/sh−7,579$6,442→ 677,579 total - Purchase
Common Stock
2023-12-06$0.90/sh−17,233$15,510→ 700,000 total
Footnotes (2)
- [F1]Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
- [F2]Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.